Cómo y cuándo el levonorgestrel previene el embarazo si se administra como anticonceptivo de emergencia

Cómo y cuándo el levonorgestrel previene el embarazo si se administra como anticonceptivo de emergencia

En esta revisión se actualiza el mecanismo de acción del levonorgestrel (LNG) usado en anticoncepción de emergencia. El análisis crítico de la estimación de la eficacia anticonceptiva del LNG indica que su tasa de falla es más alta que la publicada. El LNG aumenta la viscosidad del moco cervical imp...

Full description

Bibliographic Details
Main Authors:	Horacio Croxatto Avoni, María Elena Ortiz Scarlazetta
Format:	Article
Language:	English
Published:	Pontificia Universidad Católica de Chile 2008-08-01
Series:	ARS Medica
Subjects:	levonorgestrel
Online Access:	https://www.arsmedica.cl/index.php/MED/article/view/116

Similar Items

Cómo y cuando el levonorgestrel previene el embarazo cuando se administra como anticonceptivo de emergencia
by: Horacio Croxatto, et al.
Published: (2007-01-01)

Cómo y cuando el levonorgestrel previene el embarazo cuando se administra como anticonceptivo de emergencia
by: Ortiz, Maria Elena, et al.
Published: (2007-01-01)

MECANISMO DE ACCIÓN DEL LEVONORGESTREL EN LA ANTICONCEPCIÓN DE EMERGENCIA
by: Horacio Croxatto A, et al.
Published: (2004-01-01)

Efecto del levonorgestrel como anticonceptivo oral de emergencia en la ovulación, el endometrio y los espermatozoides Effect of levonorgestrel in the ovulation, endometrium, and spermatozoa for emergency oral contraception
by: Víctor J. Suárez, et al.
Published: (2010-06-01)

ANTICONCEPCIÓN HORMONAL DE EMERGENCIA Y EMBARAZO ECTÓPICO: CASO CLÍNICO
by: Guillermo Rosa W, et al.
Published: (2009-01-01)

Influencia de polimorfismos genéticos de CYP3A4/5 en la farmacocinética de levonorgestrel: estudio piloto
by: Iván Moreno, et al.
Published: (2012-12-01)

Multifetal Pregnancy Following Emergency Contraceptive Pill Containing Levonorgestrel: Case Report
by: Yavuz Şimşek, et al.
Published: (2010-12-01)

Anticoncepción con el dispositivo liberador de levonorgestrel: ¿Cuál es su lugar en el sangrado uterino anormal?
by: Cristian Alberto Zumárraga Pozo, et al.
Published: (2022-08-01)

Mecanismos de acción de la anticoncepción hormonal de emergencia: efectos del levonorgestrel anteriores y posteriores a la fecundación Mechanisms of action of emergency contraception
by: Marta Durand, et al.
Published: (2009-06-01)

Comparison of the Effects of Copper T and Levonorgestrel IUD on Proteoglycan Composition of Cervical Mucus
by: Yeşim Bayoğlu Tekin, et al.
Published: (2016-05-01)

In vitro assessment of some sperm function following exposure to levonorgestrel in human fallopian tubes
by: Hermanny Alexia, et al.
Published: (2012-01-01)

Effects of Levonorgestrel and progesterone on Oviductal physiology in mammals
by: Cheng Li, et al.
Published: (2018-06-01)

DISPOSITIVOS INTRAUTERINOS CON LEVONORGESTREL: UNA NUEVA ALTERNATIVA TERAPÉUTICA EN EL SANGRADO UTERINO ANORMAL DE ORIGEN ORGÁNICO
by: Patricio Valdés G, et al.
Published: (2004-01-01)

Efficacy of etonogestrel subcutaneous implants versus the levonorgestrel-releasing intrauterine system in the conservative treatment of adenomyosis
by: Wei Anwen, et al.
Published: (2024-03-01)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
by: Hira Imad Cheema, et al.
Published: (2017-11-01)

Metformin versus levonorgestrel-releasing intrauterine system in the management of endometrial hyperplasia: a randomized clinical trial
by: Omima T. Taha, et al.
Published: (2023-08-01)

Migration of a Levonorgestrel - Releasing Intrauterine Device (Lng-Iud): Can We Trust on Ultrasound Image?
by: Helena von Eye Corleta, et al.
Published: (2010-04-01)

Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
by: Amarjitsing Rajput, et al.
Published: (2022-04-01)

Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
by: Barbara Zantut Wittmann, et al.
Published: (2020-05-01)

Comparison of levonorgestrel level and creamatocrit in milk following immediate versus delayed postpartum placement of the levonorgestrel IUD
by: Niaree G. Hopelian, et al.
Published: (2021-01-01)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
by: Fariba Behnamfar, et al.
Published: (2014-01-01)

Over-The-Counter Availability of Levonorgestrel Emergency Contraception in Pharmacies on Oahu
by: Jennifer Chin, et al.
Published: (2020-02-01)

Evaluation of Levonorgestrel Subdermal Implant as Long Term Reversible Contraceptive
by: Taqdees Iftikhar, et al.
Published: (2018-06-01)

Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial
by: Jennifer H. Tang, et al.
Published: (2020-01-01)

Levonorgestrel Implant Continuation among Postpartum Women Admitted to the Department of Obstetrics and Gynecology of a Tertiary Care Centre
by: Samata Nepal, et al.
Published: (2023-09-01)

A Randomized, Controlled Trial of Levonorgestrel Vs. The Yuzpe Regimen as Emergency Contraception Method among Iranian Women.
by: Fatemeh Sadat Hoseini, et al.
Published: (2013-10-01)

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
by: Dore M, et al.
Published: (2021-10-01)

Seguridad y aceptabilidad del sistema intrauterino liberador de levonorgestrel 52 mg en mujeres con hemorragia uterina anormal en un centro de atención ambulatoria en Bogotá, Colombia, 2012-2016
by: Patricia Sandoval-Vivas
Published: (2020-10-01)

Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system is effective for long-term management of adenomyosis
by: Jilan Jiang, et al.
Published: (2024-01-01)

Levonorgestrel-releasing intrauterine device versus oral progesterone for treatment of simple endometrial hyperplasia without atypia
by: Hatice Kansu-Celik, et al.
Published: (2018-03-01)

Ethinylestradiol and Levonorgestrel as Active Agents in Normal Skin, and Pathological Conditions Induced by UVB Exposure: In Vitro and In Ovo Assessments
by: Dorina Coricovac, et al.
Published: (2018-11-01)

Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis
by: Dong Soo Park, et al.
Published: (2015-08-01)

COMPARATIVE ANALYSIS OF REQUIREMENTS FOR QUALITY CONTROL OF ETHINYL ESTRADIOL AND LEVONORGESTREL CONTAINING MEDICINAL PRODUCTS
by: V. I. Seredenko, et al.
Published: (2018-03-01)

Oral ethinylestradiol–levonorgestrel therapy counteracts fructose-induced renal metabolic impairment in female rats
by: Kehinde Samuel Olaniyi, et al.
Published: (2021-09-01)

Comparative study of the levonorgestrel intrauterine system and laparoscopic hysterectomy for the treatment of heavy menstrual bleeding in enlarged uteri
by: Daniella De Batista Depes, et al.
Published: (2023-04-01)

Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD
by: Seyed Javad Purafzali Firuzabadi, et al.
Published: (2012-01-01)

The reproductive inhibitory effects of levonorgestrel, quinestrol, and EP-1 in Brandt’s vole (Lasiopodomys brandtii)
by: Luye Shi, et al.
Published: (2020-06-01)

An innovative surgical approach: suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis
by: Huizhi Zhang, et al.
Published: (2022-11-01)

Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system
by: Osama Shawki, et al.
Published: (2013-01-01)

Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding
by: Navneet Magon, et al.
Published: (2013-01-01)